PRIA Logo™
MassachusettsH 4607194th General Court (2025-2026)House

An Act relative to increasing access to epinephrine

Sponsored By: Joint Committee on Public Health

Second Reading

Public HealthHealth Care FinancingHouse Ways and MeansHouse Steering, Policy and Scheduling with the amendment pending

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Joint Committee on Public Health

    Affiliation unavailable

Cosponsors

  • Adrian C. Madaro

    Democratic • House

  • Bridget Plouffe

    Democratic • House

  • Bruce J. Ayers

    Democratic • House

  • Carmine Lawrence Gentile

    Democratic • House

  • Christopher J. Worrell

    Democratic • House

  • Christopher Richard Flanagan

    Democratic • House

  • Estela A. Reyes

    Democratic • House

  • Greg Schwartz

    Democratic • House

  • James B. Eldridge

    Democratic • Senate

  • James C. Arena-DeRosa

    Democratic • House

  • John F. Keenan

    Democratic • Senate

  • John Francis Moran

    Democratic • House

  • Julian Cyr

    Democratic • Senate

  • Marc T. Lombardo

    Republican • House

  • Marcus S. Vaughn

    Republican • House

  • Michelle L. Badger

    Democratic • House

  • Natalie M. Higgins

    Democratic • House

  • Patrick Joseph Kearney

    Democratic • House

  • Patrick M. O'Connor

    Republican • Senate

  • Ryan M. Hamilton

    Democratic • House

  • Samantha Montaño

    Democratic • House

  • Susannah M. Whipps

    Independent • House

  • Thomas W. Moakley

    Democratic • House

Roll Call Votes

All Roll Calls

Yes: 54 • No: 0

committee vote • 5/19/2026

Committee Favorable with Amendment: H.4607 “An Act relative to increasing access to epinephrine” as amended

Yes: 30 • No: 0

committee vote • 11/21/2025

Committee Favorable: H4607 reported favorably

Yes: 13 • No: 0

committee vote • 10/8/2025

Committee Redraft: Shall the bill be reported favorably with a new draft, accompanied by H2503 and H2367?

Yes: 11 • No: 0

Actions Timeline

  1. New draft substituted, see H5443

    5/20/2026House

  2. Read second, amended (as recommended by the committee on House Ways and Means)

    5/20/2026House

  3. Rules suspended

    5/20/2026House

  4. Committee reported that the matter be placed in the Orders of the Day for the next sitting for a second reading with the amendment pending

    5/20/2026House

  5. Referred to the committee on House Steering, Policy and Scheduling with the amendment pending

    5/20/2026House

  6. Committee recommended ought to pass with an amendment, substituting therefor a bill with the same title, see H5443

    5/20/2026House

  7. Committee recommended bill ought to pass and referred to the committee on House Ways and Means

    12/4/2025House

  8. Reported favorably by committee and referred to the committee on Health Care Financing

    10/16/2025House

  9. New draft of H2367, H2500 and H2503

    10/16/2025House

  10. Reported from the committee on Public Health

    10/16/2025House

Bill Text

Related Bills

Back to State Legislation